Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
OBJECTIVE: To analyze damage occurring in patients with Wegener's granulomatosis (WG) enrolled in the WG Etanercept Trial (WGET) and to correlate that damage with disease activity, adverse events, and quality of life. METHODS: The Vasculitis Damage Index (VDI) was applied to all 180 patients a...
主要な著者: | Seo, P, Min, Y, Holbrook, J, Hoffman, G, Merkel, P, Spiera, R, Davis, J, Ytterberg, SR, St Clair, E, McCune, W, Specks, U, Allen, N, Luqmani, R, Stone, J |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2005
|
類似資料
-
Damage from Wegener's granulomatosis and its treatment: Prospective data from the Wegener's granulomatosis Etanercept Trial (WGET).
著者:: Seo, P, 等
出版事項: (2004) -
Design of the Wegener's Granulomatosis Etanercept Trial (WGET)
著者:: Stone, J, 等
出版事項: (2002) -
Granulomatosis with polyangiitis (Wegener's): An alternative name for Wegener's granulomatosis
著者:: Falk, R, 等
出版事項: (2011) -
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
著者:: Falk, R, 等
出版事項: (2011) -
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
著者:: Falk, R, 等
出版事項: (2011)